Andres
Iñiguez Romo
Hospital General Universitario de Alicante
Alicante, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (35)
2024
-
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial
Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225
2023
-
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
American Journal of Cardiology, Vol. 190, pp. 32-40
2022
-
Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial
Journal of the American Heart Association, Vol. 11, Núm. 23
-
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396
-
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973
2021
-
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178
2020
-
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial
EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921
-
Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design
American Heart Journal, Vol. 222, pp. 174-182
2019
-
Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial
Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925
-
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design
Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70
-
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial
Circulation, Vol. 140, Núm. 23, pp. 1904-1916
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
-
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: Insights from five-year follow-up of the EXAMINATION trial
EuroIntervention, Vol. 13, Núm. 16, pp. 1939-1945
-
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
PLoS ONE, Vol. 13, Núm. 8
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
-
Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial)
American Journal of Cardiology, Vol. 121, Núm. 9, pp. 1039-1045
2017
-
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486
-
Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST–Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation
American Journal of Cardiology, Vol. 120, Núm. 9, pp. 1460-1466
-
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: Insights from the five-year follow-up of the EXAMINATION trial
EuroIntervention, Vol. 13, Núm. 5, pp. e557-e563
2016
-
A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 6, pp. 355-361